Slavica Vučković

3.6k total citations
58 papers, 2.3k citations indexed

About

Slavica Vučković is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Slavica Vučković has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Immunology, 18 papers in Hematology and 13 papers in Molecular Biology. Recurrent topics in Slavica Vučković's work include Immunotherapy and Immune Responses (31 papers), T-cell and B-cell Immunology (29 papers) and Immune Cell Function and Interaction (24 papers). Slavica Vučković is often cited by papers focused on Immunotherapy and Immune Responses (31 papers), T-cell and B-cell Immunology (29 papers) and Immune Cell Function and Interaction (24 papers). Slavica Vučković collaborates with scholars based in Australia, United States and New Zealand. Slavica Vučković's co-authors include Derek N.J. Hart, Geoffrey R. Hill, Yuko Osugi, Mark J. Smyth, Camille Guillerey, Prahlad V. Raninga, Kathryn F. Tonissen, Giovanna Di Trapani, Kelli P. A. MacDonald and A Wilkinson and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Slavica Vučković

57 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Slavica Vučković Australia 28 1.5k 716 588 530 146 58 2.3k
Gary C. Starling United States 28 1.6k 1.1× 894 1.2× 658 1.1× 417 0.8× 135 0.9× 59 2.6k
Véronique Mateo France 19 1.4k 0.9× 806 1.1× 315 0.5× 244 0.5× 187 1.3× 26 2.2k
Tiffany Hughes United States 24 2.1k 1.4× 664 0.9× 929 1.6× 577 1.1× 104 0.7× 38 2.9k
Bente Lowin Switzerland 10 1.1k 0.8× 759 1.1× 376 0.6× 312 0.6× 279 1.9× 10 1.9k
Mattias Carlsten Sweden 28 2.4k 1.6× 621 0.9× 1.5k 2.6× 474 0.9× 81 0.6× 63 3.1k
Helen C. O’Neill Australia 25 1.3k 0.9× 699 1.0× 246 0.4× 359 0.7× 96 0.7× 123 2.2k
Yusuke Shono Japan 16 680 0.5× 575 0.8× 389 0.7× 457 0.9× 244 1.7× 41 1.6k
Giovanna Carrà Italy 20 1.1k 0.7× 580 0.8× 365 0.6× 177 0.3× 146 1.0× 59 1.9k
Jan E. Ehlert Germany 14 896 0.6× 587 0.8× 970 1.6× 190 0.4× 101 0.7× 27 2.1k
Li-Zhen He United States 22 812 0.5× 1.5k 2.1× 495 0.8× 593 1.1× 94 0.6× 41 2.2k

Countries citing papers authored by Slavica Vučković

Since Specialization
Citations

This map shows the geographic impact of Slavica Vučković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slavica Vučković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slavica Vučković more than expected).

Fields of papers citing papers by Slavica Vučković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Slavica Vučković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slavica Vučković. The network helps show where Slavica Vučković may publish in the future.

Co-authorship network of co-authors of Slavica Vučković

This figure shows the co-authorship network connecting the top 25 collaborators of Slavica Vučković. A scholar is included among the top collaborators of Slavica Vučković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Slavica Vučković. Slavica Vučković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joshua, Douglas, Slavica Vučković, James Favaloro, et al.. (2021). Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma. Frontiers in Immunology. 12. 620596–620596. 14 indexed citations
2.
Raninga, Prahlad V., et al.. (2021). Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma. Oncotarget. 12(9). 948–949.
3.
Wilkinson, A, Rachel D. Kuns, Andrea Henden, et al.. (2019). IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling. Blood. 134(23). 2092–2106. 32 indexed citations
4.
Wilkinson, A, Kate H. Gartlan, Greg Kelly, et al.. (2018). Granulocytes Are Unresponsive to IL-6 Due to an Absence of gp130. The Journal of Immunology. 200(10). 3547–3555. 29 indexed citations
5.
Minnie, Simone A., Rachel D. Kuns, Kate H. Gartlan, et al.. (2018). Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade. Blood. 132(16). 1675–1688. 125 indexed citations
6.
Raninga, Prahlad V., Giovanna Di Trapani, Slavica Vučković, & Kathryn F. Tonissen. (2016). TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition. Cell Cycle. 15(4). 559–572. 47 indexed citations
7.
Raninga, Prahlad V., Giovanna Di Trapani, Slavica Vučković, & Kathryn F. Tonissen. (2016). Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation. APOPTOSIS. 21(12). 1422–1437. 16 indexed citations
8.
Wilkinson, A, Adi Idris, Ben Fancke, et al.. (2014). FLT3-Ligand Treatment of Humanized Mice Results in the Generation of Large Numbers of CD141+ and CD1c+ Dendritic Cells In Vivo. The Journal of Immunology. 192(4). 1982–1989. 86 indexed citations
9.
Sanchez, Washington Y., Sean L. McGee, Timothy Connor, et al.. (2013). Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib. British Journal of Cancer. 108(8). 1624–1633. 119 indexed citations
10.
Fadilah, S A W, et al.. (2007). Cord Blood CD34 + Cells Cultured with FLT3L, Stem Cell Factor, Interleukin-6, and IL-3 Produce CD11c + CD1a − /c − Myeloid Dendritic Cells. Stem Cells and Development. 16(5). 849–856. 10 indexed citations
11.
Lau, Jenny, Mary Sartor, Kenneth F. Bradstock, et al.. (2007). Activated Circulating Dendritic Cells After Hematopoietic Stem Cell Transplantation Predict Acute Graft-Versus-Host Disease. Transplantation. 83(7). 839–846. 37 indexed citations
12.
Radford, Kristen J., Cameron J. Turtle, Andrew J. Kassianos, et al.. (2005). Immunoselection of Functional CMRF-56+ Blood Dendritic Cells from Multiple Myeloma Patients for Immunotherapy. Journal of Immunotherapy. 28(4). 322–331. 14 indexed citations
13.
Vučković, Slavica, Dalia Khalil, Nicola Angel, et al.. (2004). The CMRF58 antibody recognizes a subset of CD123hi dendritic cells in allergen-challenged mucosa. Journal of Leukocyte Biology. 77(3). 344–351. 3 indexed citations
14.
Vučković, Slavica, Kenneth A. Field, Devinder Gill, et al.. (2003). Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay. Journal of Immunological Methods. 284(1-2). 73–87. 69 indexed citations
15.
López, J. Alejandro, Gilles Bioley, Cameron J. Turtle, et al.. (2003). Single step enrichment of blood dendritic cells by positive immunoselection. Journal of Immunological Methods. 274(1-2). 47–61. 35 indexed citations
16.
Vučković, Slavica, et al.. (2001). CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. The American Journal of Gastroenterology. 96(10). 2946–2956. 60 indexed citations
17.
Kato, Masato, et al.. (2000). Expression of multilectin receptors and comparative FITC–dextran uptake by human dendritic cells. International Immunology. 12(11). 1511–1519. 135 indexed citations
18.
Vučković, Slavica, et al.. (1999). Dendritic cells in chronic myelomonocytic leukaemia. British Journal of Haematology. 105(4). 974–985. 34 indexed citations
19.
Vukmanović, Stanislav, Slavica Vučković, Stanislava Stošić‐Grujičić, Zorica Ramić, & Mario Abinun. (1992). An unusual T-cell surface phenotype in vivo correlates with the failure to proliferate and produce IL-2 in vitro in a patient with common variable immunodeficiency. Clinical Immunology and Immunopathology. 65(3). 261–270. 7 indexed citations
20.
Vučković, Slavica, et al.. (1988). Corneal perforation in Mooren's ulcer — immunological and clinical follow-up. Graefe s Archive for Clinical and Experimental Ophthalmology. 226(4). 330–331. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary C. Starling Breakdown of academic impact, for papers by Véronique Mateo Breakdown of academic impact, for papers by Tiffany Hughes Breakdown of academic impact, for papers by Bente Lowin Breakdown of academic impact, for papers by Mattias Carlsten Breakdown of academic impact, for papers by Helen C. O’Neill Breakdown of academic impact, for papers by Yusuke Shono Breakdown of academic impact, for papers by Giovanna Carrà Breakdown of academic impact, for papers by Jan E. Ehlert Breakdown of academic impact, for papers by Li-Zhen He
Rankless by CCL
2026